SHASQI
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ (Click Activated Protodrugs Against Cancer) platform. The technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two ‘click’, a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds. We have already proven that our platform works in humans, which opens up an array of future possibilities for click-chemistry based therapies.
SHASQI
Industry:
Biotechnology Emergency Medicine Health Care Medical
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.shasqi.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
64.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Global Site Tag Microsoft Exchange Online
Similar Organizations
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Shasqi
William J. Rieflin
William J. Rieflin investment in Series B - Shasqi
Juan Jaen
Juan Jaen investment in Series B - Shasqi
National Cancer Institute
National Cancer Institute investment in Grant - Shasqi
Endpoint Ventures
Endpoint Ventures investment in Series A - Shasqi
Y Combinator
Y Combinator investment in Series A - Shasqi
Y Combinator
Y Combinator investment in Pre Seed Round - Shasqi
Newest Events participated
Participated in Y Combinator Winter 2015 Demo Day
on 2015-03-23 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.shasqi.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.51 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Shasqi"
About Shasqi
Shasqi’s leadership has diverse backgrounds, a wealth of experience, and is supported by a Scientific Advisory Board of distinguished oncology leaders. Learn more. From concept to …See details»
Shasqi
Shasqi uses click chemistry to target cancer drugs directly to the tumor, minimizing side effects and potentially improving the therapeutic indexSee details»
Shasqi - Crunchbase Company Profile & Funding
Shasqi closed its last funding round on Dec 8, 2021 from a Grant round. Who are Shasqi 's competitors? Alternatives and possible competitors to Shasqi may include Entrada Therapeutics , ArrePath , and Soligenix .See details»
Shasqi Company Profile | Management and Employees List
Shasqi Profile and History. Shasqi is a privately held, clinical-stage biotechnology company whose mission is to enable patients to beat cancer with tumor-localized therapies. Shasqi leverages …See details»
Shasqi, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
SAN FRANCISCO, April 5, 2024 /PRNewswire/ -- Shasqi, Inc. ("Shasqi"), a biotech company whose mission is to make cancer drugs more effective with click chemistry, today announced it …See details»
SHASQI, INC. Company Profile | San Francisco, CA | Competitors ...
Find company research, competitor information, contact details & financial data for SHASQI, INC. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Shasqi Company Profile: Overview and Full News Analysis
Shasqi is a California-based company pioneering the field of tumor-targeted cancer therapy using their proprietary Click Activated Protodrugs Against Cancer (CAPAC®) approach. They are …See details»
Shasqi Company Overview, Contact Details & Competitors | LeadIQ
Nov 11, 2021 Shasqi is a biotech company whose mission is to revolutionize cancer treatment with click chemistry, a 2022 Nobel Prize winning technology. Our unique CAPAC® (Click …See details»
Shasqi Company Profile - Office Locations, Competitors, Revenue …
Shasqi has 5 employees at their 1 location and $10.12 m in total funding,. See insights on Shasqi including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Shasqi - LinkedIn
Shasqi is a biotech company whose mission is to revolutionize cancer treatment with click chemistry, a 2022 Nobel Prize winning technology. Our unique CAPAC® (Click Activated …See details»
Shasqi leadership
Elliott Levy MD Dr. Levy is an industry veteran with over 25 years of drug development experience in leadership roles at global pharmaceutical companies, including Amgen and Bristol-Myers …See details»
Shasqi - UCSF Rosenman Institute
Sep 20, 2022 Shasqi Founders Pledge Our technology, based on bioorthogonal chemistry, enables the activation of small molecule drugs at the local tissue-level, improving both their …See details»
Shasqi - Overview, News & Similar companies | ZoomInfo.com
Mar 10, 2024 Shasqi is a privately held, clinical-stage biotechnology company whose mission is to enable patients to beat cancer with tumor-localized therapies. Shasqi leverages its …See details»
SHASQI, INC - VentureRadar
" Shasqi is a privately held, clinical stage biotechnology company whose mission is to enable patients to beat cancer without poisoning their bodies. Shasqi leverages its proprietary Click …See details»
Shasqi - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Pre Seed Round - Shasqi . 1: …See details»
The first company to use Nobel-winning click chemistry in humans …
Oct 27, 2022 The breakthrough tech: Shasqi’s lead asset of its proprietary Click Activated Protodrugs Against Cancer (CAPAC) platform injects a biopolymer directly into a target tumor …See details»
Contact Shasqi
We're always looking forward to connecting with others who are passionate about advancing precision targeted cancer therapies to bring its full potential to patients.See details»
Shasqi Awarded a Second NCI Grant of $1.9M to Accelerate the ...
Dec 8, 2021 Shasqi leverages its proprietary CAPAC Platform to develop precision oncology therapeutics designed to deliver unprecedented doses precisely focused at the tumor with an …See details»
Our Pipeline - Shasqi
Our technology can transform antigen-targeted drugs, increasing the activity and lowering the toxicities. Since we don’t rely on internalization for activation, this expands the targets that can …See details»